Overall survival in patients with ALCL, stratified by rearrangements of ALK, DUSP22, and TP63. −/−/−, triple-negative cases lacking all 3 rearrangements. See Figure 1B in the article by Parilla Castellar et al that begins on page 1473.
Overall survival in patients with ALCL, stratified by rearrangements of ALK, DUSP22, and TP63. −/−/−, triple-negative cases lacking all 3 rearrangements. See Figure 1B in the article by Parilla Castellar et al that begins on page 1473.
